Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Systemic infections caused by Candida species are an important cause of morbidity and mortality among immunocompromised and non-immunocompromised patients. In particular, Candida glabrata is an emerging species within the Candida family that causes infections ranging from superficial to life-threate...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamal, Ahmed, Chu, Sherman, McCormick, Thomas S., Borroto-Esoda, Katyna, Angulo, David, Ghannoum, Mahmoud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006402/
https://www.ncbi.nlm.nih.gov/pubmed/33791244
http://dx.doi.org/10.3389/fcimb.2021.642358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006402/
https://www.ncbi.nlm.nih.gov/pubmed/33791244
http://dx.doi.org/10.3389/fcimb.2021.642358

Ejemplares similares